论文部分内容阅读
最近,基于疗效、毒性、耐药性预测与监控生物标志物的肿瘤个性化治疗(精准医疗)正在不断重塑抗肿瘤药物包括免疫治疗药物的研究研发与治疗应用的理念与过程。为促进我国抗肿瘤药物研究和应用的交流,及时了解国际国内相关领域的最新进展和动态,由中国工程院医药卫生学部和中国抗癌协会抗癌药物专业委员会、中国药理学会肿瘤药理专业委员会联合主办,杭州市第一人民医院集团(南京医科大学附属杭州医院)、浙江大学药学院联合承办的“2017医学前沿论坛暨第十
Recently, personalized cancer therapy (Precision Medicine) based on efficacy, toxicity, drug resistance prediction and monitoring of biomarkers is continually reshaping the philosophy and process of research and development and therapeutic applications of anti-cancer drugs, including immunotherapeutics. To promote the exchange of research and application of antitumor drugs in our country, keep abreast of the latest developments and developments in relevant fields both at home and abroad, co-sponsored by the Chinese Academy of Engineering Department of Medical Hygiene and the Anti-Cancer Drug Committee of China Anti-Cancer Association and the Oncology Pharmacology Committee of Chinese Pharmacological Society , Hangzhou First People’s Hospital Group (Nanjing Medical University Affiliated Hangzhou Hospital), Zhejiang University School of Pharmacy jointly hosted the ”2017 Medical Frontier Forum and the tenth